Neuroprotection · Progesterone · TBI General

ProTECT III -Progesterone in TBI, Another Step Towards Futility

ProTECT III, the results of which were published alongside those of the SYNAPSE-trial in the December 25 2014 issue of NEJM, demonstrates no patient-important advantage conferred by the administration of progesterone (albeit very early in this particular study) to TBI patients.

“This clinical trial did not show a benefit of progesterone over placebo in the improvement of outcomes in patients with acute TBI”

Very Early Administration of Progesterone for Acute Traumatic Brain Injury. Wright et al. NEJM 2014. Read the article here.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s